This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
July 10, 2015
Completion of NOK 200 million private placement
July 10, 2015
Orexo Interim report January-June 2015
July 08, 2015
Trimb and Avista Capital Partners form strategic partnership
July 02, 2015
Closing of the acquisition of Oncos Therapeutics Oy
July 02, 2015
Wilson Therapeutics Appoints Hans Schikan to its Board of Directors
July 02, 2015
Cortendo Provides 2015 Half-Year Update on Corporate Progress
July 01, 2015
Lancet Publication of Sham-Controlled Clinical Trial Shows Pulmonx’s Zephyr Endobronchial Valves Deliver Significant Benefit to Emphysema Patients
June 25, 2015
Orexo’s “Out the Monster” campaign wins a Gold Lions Health Award at the Cannes Lions Festival
June 17, 2015
WILSON THERAPEUTICS ANNOUNCES SUPPORT OF THE BIG WOW TO RAISE AWARENESS OF WILSON’S DISEASE
June 17, 2015
UPDATED RESULTS OF ONGOING PHASE 1/2 STUDY WITH BETALUTIN™ IN RELAPSED CD37+ NON-HODGKIN LYMPHOMA PATIENTS